IN2015KO00268A - - Google Patents
Download PDFInfo
- Publication number
- IN2015KO00268A IN2015KO00268A IN268KO2015A IN2015KO00268A IN 2015KO00268 A IN2015KO00268 A IN 2015KO00268A IN 268KO2015 A IN268KO2015 A IN 268KO2015A IN 2015KO00268 A IN2015KO00268 A IN 2015KO00268A
- Authority
- IN
- India
- Prior art keywords
- sitosterol
- glucoside
- relates
- present
- cancer drug
- Prior art date
Links
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 229940076810 beta sitosterol Drugs 0.000 abstract 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 abstract 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229950005143 sitosterol Drugs 0.000 abstract 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 abstract 1
- 229940096998 ursolic acid Drugs 0.000 abstract 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN268KO2015 IN2015KO00268A (enExample) | 2015-03-11 | 2015-03-11 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN268KO2015 IN2015KO00268A (enExample) | 2015-03-11 | 2015-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015KO00268A true IN2015KO00268A (enExample) | 2015-04-17 |
Family
ID=54393599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN268KO2015 IN2015KO00268A (enExample) | 2015-03-11 | 2015-03-11 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2015KO00268A (enExample) |
-
2015
- 2015-03-11 IN IN268KO2015 patent/IN2015KO00268A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123845T1 (el) | Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων | |
| PH12016500094A1 (en) | Autotaxin inhibitors | |
| MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
| MX2015011132A (es) | Moduladores policiclicos del receptor de estrogenos y sus usos. | |
| CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
| BR112017001221A2 (pt) | derivados de indolizina que são aplicáveis a doenças neurodegenerativas | |
| IN2013MU03641A (enExample) | ||
| MX2017015137A (es) | Composicion farmaceutica oral de dosis diaria de isotretinoin. | |
| BR112017014414A2 (pt) | formulação farmacêutica | |
| MX2016015261A (es) | Dispersion solida de allisartan isoproxilo y su composicion. | |
| MX2016014179A (es) | Derivados quinazolindiona farcologicamente activos. | |
| IN2014CH00840A (enExample) | ||
| MX364528B (es) | Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas. | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| GB2527233A (en) | Composition comprising hydrocortisone | |
| PH12019500992A1 (en) | Directly tablettable matrix for producing tablets with extended active substance delivery | |
| TN2015000093A1 (en) | Isoxazolidine derivatives | |
| MX2020007270A (es) | Formulacion parenteral que comprende siponimod. | |
| IL261929B (en) | Stable pharmaceutical preparations for topical administration and their use | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| IN2015KO00268A (enExample) | ||
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
| DOP2015000290A (es) | Benzoxazoles sustituidos | |
| GR1008039B (el) | Σταθερο ενεσιμο φαρμακευτικο σκευασμα ενος αγωνιστη των υποδοχεων της βιταμινης d και μεθοδος για την παρασκευη αυτου |